# OnCo record paper-friedman-cancer-discov (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-friedman-cancer-discov/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-friedman-cancer-discov" ;
  schema:name "Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study"@en ;
  schema:description "Paper cited by one trial page, indexed on Europe PMC as PubMed record 34876409 and published in Cancer Discovery; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-friedman-cancer-discov/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/2159-8290.cd-21-0450>, <https://pubmed.ncbi.nlm.nih.gov/34876409/>, <https://europepmc.org/article/MED/34876409> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1158/2159-8290.cd-21-0450> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Friedman CF, Hainsworth JD, Kurzrock R, et al." ;
  onco:trials <https://onco.cc/trials/mypathway/> ;
  onco:journals <https://onco.cc/journals/cancer-discovery/> .